Generics of Tecfidera not available in Europe until at least 2025

[bxrmom]

Received an email about this today:

European Commission decision supports Biogen's pursuit of market exclusivity

The European Commission (EC) has withdrawn its marketing authorizations for generic versions of Tecfidera (dimethyl fumarate), an oral therapy approved in Europe for relapsing-remitting multiple sclerosis (RRMS).

multiplesclerosisnewstoday....

[mrsmike9]

That's odd. I wonder why?

[bxrmom in reply to mrsmike9]

I personaly think it has do with money and control. But this is what the website says:

According to Biogen, which developed and markets the brand-name medication, the decision ensures Biogen will have full data and marketing protection for Tecfidera at least until Feb. 3, 2025. That means it will be the sole dimethyl fumarate MS therapy that may be marketed for sale legally in the European Union.

[mrsmike9 in reply to bxrmom]

I hate when it's about $$ and not about people.

[bxrmom in reply to mrsmike9]

Same for me! And I think that is what it comes down to in this case even though they aren't coming out and saying it